Original Source(s)
Ivarmacitinib Eased Refractory PCA: Case Report
-
by Andrea Surnit
May 20, 2026
Related Content
Combination Therapy Shows Potential in Psoriasis, Obesity
Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.
May 20, 2026
-
5 min
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
Guselkumab Shows Psoriasis Benefit in Darker Skin Tones
Randomized trial suggests sustained clearance across darker skin tones.
May 14, 2026
-
3 min
